Survival with inoperable lung cancer. An integration of prognostic variables based on simple clinical criteria

Cancer

Volumn 39, Issue 1, 1977, Pages 303-313

  Lanzotti, Victor J ^a   Thomas, David R ^a,b   Boyle, Liam E ^a   Smith, Terry L ^a   Gehan, Edmund A ^a   Samuels, Melvin L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BODY WEIGHT; CANCER MORTALITY; DIAGNOSIS; FATALITY; HISTOLOGY; LUNG CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; THERAPY;

AGE FACTORS; AGED; BODY WEIGHT; CLAVICLE; HUMANS; LIFE EXPECTANCY; LUNG NEOPLASMS; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PROGNOSIS; REGRESSION ANALYSIS;

EID: 0017350721     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(197701)39:1<303::AID-CNCR2820390147>3.0.CO;2-U     Document Type: Article

References (33)

1. A generalized Kruskal‐Wallis test for comparing k samples subject to unequal patterns of censorship
2. Covariance analysis of censored survival data
3. Survival rates of lung cancer according to histologic type
4. Immunocompetence in under‐nutrition
5. Regression models and life tables
6. Small cell carcinoma of the lung: Staging, paraneoplastic syndromes, treatment, and survival
7. Observer variability in the histopathologic diagnosis of lung cancer
8. The diverse effects of histopathology on manifestations and outcome of lung cancer
9. Impaired cellular immunity in kwashiorkor with improvement after therapy
10. A generalized Wilcoxon test for comparing arbitrarily single censored samples
11. Chemotherapy of bronchogenic small cell carcinoma
12. Cy‐clophosphamide, vincristine and sequential split‐course radiotherapy in the treatment of small cell lung cancer
13. Natural course of inoperable lugn cancer
14. Cell type and the natural history of lung cancer
15. Humoral and cellular immune responses to streptocci, influenza, and other antigens in Australian aboriginal school children
16. The use of ntrogen mustards in the palliative treatment of carcinoma. (With particular reference to bronchogenic carcinoma)
17. The effect of histological cell type on the prognosis of patients with bronchogenic carcinoma
18. Cancer chemotherapeutic response and intravenous hyperalimentation
19. Pretreatment classification and staging of bronchogenic carcinoma
20. Im‐munocompetence of patients with protein‐calorie malnutrition: The effects of nutritional repletion
21. COMB (cyclophosphamide, oncovin, methyl‐CCNU, and bleomycin): A four‐drug combination in solid tumors
22. Reliability of cytologic diagnosis in cancer of the lung
23. Survival of lung cancer patients vis‐a‐vis therapy and cell type
24. Panel report: Morphologic classification of bronchogenic carcinoma
25. A system for the clinical staging of lung cancer
26. Combination chemotherapy in oat cell carcinoma of the lung
27. Combination chemotherapy with bleomycin, vincristine, and methotrexate plus split‐course radiotherapy in the treatment of non‐oat cell bronchogenic carcinoma
28. Keynote address on biostatistics and data retrieval
29. Panel report: Interdisciplinary group on clinical trials (biostatistics)
30. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide